Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-SK-A esketamine for acute postoperative pain in adults
ChiCTR2100052593Phase 4Recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine in acute postoperative pain (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: Vital signs and physical examination, Pain assessment and 4 more. Started Nov 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2100052593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052593.